Don't you think it is important to know that the molecules that Regen used are no longer available to them as Lilly shut down their OIDD program in early 2019. It is why you stopped hearing about it. What ever Regen found ended up being of no interest to Lilly as the OIDD program allowed for further collaboration if Lilly though Regen found something ground breaking.
I already posted about this but seems that there is more currency in hyping old, no longer valid press releases of things no longer being done than the actual truth of what is really happening.
Lilly closed the doors on their OIDD program and Regen in 2019.
I am 100% sure that Koos will confirm this.
If you need confirmation, here's Lilly's website of the program that Regen was using to screen lilly's library of molecules, molecules they no longer have access to. The website was SHUT DOWN along with the program. UNDENIABLE!
This is particularly pointed when considering the case of Eli Lilly & Co. a pioneer of open innovation, with their early entry into, and success with, the Open Innovation and Drug Discovery (OIDD) platform, but for which seemingly no trace is now found online, despite numerous earlier publications and an open way of documenting available web resources [12,16,17] (e.g.: https:// openinnovation.lilly.com/dd/what-we-offer/).